Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals

Novo Nordisk is actively seeking deals, according to CEO Mike Doustdar. The company, known for Ozempic and Wegovy, is looking for more deals than ever before. This indicates a strategic expansion or partnership effort by the drugmaker.